Author(s)

Stéphane Méo Ikama^1*, Joffode Mobet Memougame¹, Jospin Makani¹, Thibaut Oko², Eric Gibrel Kimbally Kaky¹, Lydie Ocini Ngolet³, Bijou Moualengue¹, Thibaut Gankama¹, Suzy Gisèle Kimbally Kaky¹

¹Department of Cardiology, University Hospital Center of Brazzaville, Brazzaville, The Republic of the Congo.
²Department of Hematology Laboratory, University Hospital Center of Brazzaville, Brazzaville, The Republic of the Congo.
³Department of Clinical Hematology, University Hospital Center of Brazzaville, Brazzaville, The Republic of the Congo.

To contribute to improving the management of patients with heart failure and anemia in Brazzaville, a prospective and descriptive study was conducted in the University Hospital of Brazzaville for nine months (January 1st to September 30, 2017). Included 57 patients hospitalized for left or global heart failure and presenting anemia. Anemia was defined by an haemoglobin level < 12 g/dL in men and <11 g/dL in women. Proportionings of the reticulocytes rate, serum iron, ferritin, erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP), electrophoresis of proteins, and evaluation of renal function by glomerular filtration rate (GFR), as well as the treatments of heart failure, and the auxiliary therapeutic ones, in particular the antithrombotic drugs, allowed aetiologic research. They were 20 men (35%) and 37 women (65%), old on average of 59 ± 17 years. The average rate of haemoglobin was 11.4 ± 1.4 g/dL. Heart failure was de novo in 24 cases (42.1%), old in 33 cases (57.9%); it was global in 54 cases (94.7%).The maintenance treatment associated diuretics in 32 cases (97%), angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) in 31 cases (94%), beta-blockers in two cases (6.1%), digoxin in four cases (12.1%), aspirin in five cases (15.1%) and anti-vitamin K in four cases (12.1%). Anemia was microcytic hypochromic in 30 cases (52.6%), normocytic normochromic in 20 cases (35.1%), and macrocytic normochromic in one case (1.7%). The main aetiologic factors were hemodilution in 46 cases (80.7%), renal insufficiency in 30 cases (52.3%), inflammation in 29 cases (50.8%), and iron deficiency in one case (1.7%). The HIV serology, carried out in 11 cases, was negative. Anemia is a frequent comorbidity among heart failure patients. Aetiologic research remains difficult in our context, and its often multifactorial origin.

Anemia, Heart Failure, Aetiologies, Congo

Ikama, S. , Memougame, J. , Makani, J. , Oko, T. , Kaky, E. , Ngolet, L. , Moualengue, B. , Gankama, T. and Kaky, S. (2023) Aetiologic Factors of Anemia During Heart Failure in Brazzaville (The Republic of the Congo). World Journal of Cardiovascular Diseases, 13, 605-612. doi: 10.4236/wjcd.2023.139053.